Product
Rituximab(RTX)
1 clinical trial
1 indication
Indication
Neuromyelitis Optica Spectrum DisordersClinical trial
A Multicentric, Retrospective, Real-Word Study to Evaluate the Efficacy and Safety of Inebilizumab Compare With Rituximab in Neuromyelitis Optica Spectrum DisordersStatus: Not yet recruiting, Estimated PCD: 2024-06-30